Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
Kaiser Permanente
AstraZeneca
Context Therapeutics Inc.
BioNTech SE
Jonsson Comprehensive Cancer Center
University of Nebraska
University of Southern California
West China Hospital
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
University of Arizona
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
University Medical Center Groningen